Architettura di Exchange Server 2003 Ivan Riservato Andrea Garattini.
DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA Milano 3 Febbraio 2009 SILVIO GARATTINI.
-
Upload
jason-reynolds -
Category
Documents
-
view
215 -
download
0
Transcript of DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA Milano 3 Febbraio 2009 SILVIO GARATTINI.
![Page 1: DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA Milano 3 Febbraio 2009 SILVIO GARATTINI.](https://reader036.fdocuments.net/reader036/viewer/2022062801/56649e3b5503460f94b2cd0f/html5/thumbnails/1.jpg)
DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA
Milano 3 Febbraio 2009
SILVIO GARATTINI
![Page 2: DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA Milano 3 Febbraio 2009 SILVIO GARATTINI.](https://reader036.fdocuments.net/reader036/viewer/2022062801/56649e3b5503460f94b2cd0f/html5/thumbnails/2.jpg)
ANIMAL EXPERIMENTS
ARE MODELS OF
CLINICAL TRIALS
![Page 3: DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA Milano 3 Febbraio 2009 SILVIO GARATTINI.](https://reader036.fdocuments.net/reader036/viewer/2022062801/56649e3b5503460f94b2cd0f/html5/thumbnails/3.jpg)
ANIMAL EXPERIMENTS CANNOT BE AT PRESENT SUBSTITUTED BY OTHER APPROACHES.
PRACTICAL AIMS ARE TO ESTABLISH
EFFICACY TOXICITY
MECHANISM OF ACTION PHARMACOKINETICS
PHARMACODYNAMICS CANCEROGENESIS
REPRODUCTION ADVERSE REACTIONS
![Page 4: DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA Milano 3 Febbraio 2009 SILVIO GARATTINI.](https://reader036.fdocuments.net/reader036/viewer/2022062801/56649e3b5503460f94b2cd0f/html5/thumbnails/4.jpg)
NEED TO EVALUATE AGREEMENT
BETWEEN ANIMAL AND CLINICAL OUTCOMES
![Page 5: DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA Milano 3 Febbraio 2009 SILVIO GARATTINI.](https://reader036.fdocuments.net/reader036/viewer/2022062801/56649e3b5503460f94b2cd0f/html5/thumbnails/5.jpg)
DISCORDANCE MAY BE RELATED TO
• EFFECT ESTIMATES BY CLINICAL TRIALS MAY BE BIASED OR IMPRECISE
• ANIMAL MODELS MAY BE INADEQUATE TO REPLICATE HUMAN PATHOLOGY
• RESULTS FROM ANIMAL EXPERIMENTS MAY BE BIASED OR IMPRECISE
![Page 6: DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA Milano 3 Febbraio 2009 SILVIO GARATTINI.](https://reader036.fdocuments.net/reader036/viewer/2022062801/56649e3b5503460f94b2cd0f/html5/thumbnails/6.jpg)
NEED OF HOMOGENUOUS METHODOLOGY
• RANDOMIZATION
• BLINDING
• INCLUSION AND EXCLUSION CRITERIA
• APPROPRIATE CONTROLS
• SIGNIFICANT END-POINTS
• EXPECTED DIFFERENCE
• CALCULATION OF SAMPLE SIZE
• STATISTICAL ANALYSIS
![Page 7: DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA Milano 3 Febbraio 2009 SILVIO GARATTINI.](https://reader036.fdocuments.net/reader036/viewer/2022062801/56649e3b5503460f94b2cd0f/html5/thumbnails/7.jpg)
N.TRIALS RANDOMIZATION ALLOCATION UNTREATED BLINDING ON SAMPLE SIZECONCEALMENT CONTROL OUTCOME CALCULATION
GROUP
A 19 2 4 7 14 -
B 08 2 0 3 04 -
C 31 6 0 - 2 0
D 16 5 0 - 16 0
A. Corticosteroids on brain trauma; B. Antifibrinolytics agaisist hemorrhageC. Corticosteroids neonatal respiratory distress syndrome; D. Bisphosphonate and osteoporosis
![Page 8: DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA Milano 3 Febbraio 2009 SILVIO GARATTINI.](https://reader036.fdocuments.net/reader036/viewer/2022062801/56649e3b5503460f94b2cd0f/html5/thumbnails/8.jpg)
META-ANALYSIS MEDLINE RECORDS
CLINICAL 1 : 1.000
ANIMAL 1 : 10.000
![Page 9: DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA Milano 3 Febbraio 2009 SILVIO GARATTINI.](https://reader036.fdocuments.net/reader036/viewer/2022062801/56649e3b5503460f94b2cd0f/html5/thumbnails/9.jpg)
ASSOCIATION BETWEEN FOUR DIMENSIONS OF METHODOLOGICAL QUALITY AND ESTIMATES
OF TREATMENT EFFECT IN THE 229 ADEQUATELY AND UNCLEARLY CONCEALED TRIALS
MEASURE OF RATIO OF ODDS RATIOSMETHODOLOGICAL QUALITY (95% CONFIDENCE INTERVAL) X2(DF) P
Allocation concealment
Adequate 1.00 (referent) 32.9 (1) < .001
Unclear 0.70 (0.62 - 0.79)
Sequence generation
Adequate 1.00 (referent) 0.31 (1) 58
Inadequate 0.95 (0.81 - 1.12)
Exclusions
No 1.00 (referent) 0.99 (1) 32
Yes 1.07 (0.94 -1.21)
Double-blinded
Yes 1.00 (referent) 6.16 (1) .01
No 0.83 (0.71 - 0.96)
Schulz et al., 1996
![Page 10: DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA Milano 3 Febbraio 2009 SILVIO GARATTINI.](https://reader036.fdocuments.net/reader036/viewer/2022062801/56649e3b5503460f94b2cd0f/html5/thumbnails/10.jpg)
SYSTEMATIC REVIEW HAS ALLOWED THE ANALYSIS OF SAMPLE SIZE
IN STUDIES OF FK506 IN ANIMAL MODELS OF STROKE; THE OBSERVED
VARIANCE SUGGESTS THAT 65 ANIMALS PER GROUP WOULD BE
NEEDED TO GIVE AN 80% CHANCE OF DETECTING AN IMPROVEMENT
IN OUTCOME OF 20%. IN FACT, THE LARGEST STUDY REPORTED
16 ANIMALS PER GROUP AND THE AVERAGE WAS EIGHT ANIMALS PER
GROUP. PERFORMING UNDERPOWERED STUDIES IS AS UNETHICAL
IN ANIMAL STUDIES AS IT IS IN HUMAN STUDIES.
Macleod et al., 2005
![Page 11: DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA Milano 3 Febbraio 2009 SILVIO GARATTINI.](https://reader036.fdocuments.net/reader036/viewer/2022062801/56649e3b5503460f94b2cd0f/html5/thumbnails/11.jpg)
Bebarta et al., 2003
![Page 12: DALLA CLINICA AL LABORATORIO: TRASLAZIONE INVERSA Milano 3 Febbraio 2009 SILVIO GARATTINI.](https://reader036.fdocuments.net/reader036/viewer/2022062801/56649e3b5503460f94b2cd0f/html5/thumbnails/12.jpg)
ANIMAL META-ANALYSIS OR SYSTEMATIC REWIEVS
• SHOULD BE DONE BEFORE PERFORMING NEW EXPERIMENTS
• ARE USEFUL TO FIND OUT OPTIMAL CONDITIONS OF TESTING
• CAN SPARE FUTILE CLINICAL TRIALS
• POOR METHODOLOGICAL QUALITY